NCT02286986View on ClinicalTrials.gov

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 18, 2014

Primary Completion Date

June 13, 2019

Study Completion Date

June 13, 2019

Conditions
Epilepsy
Interventions
DRUG

Cannabidiol

Trial Locations (1)

84113

University of Utah School of Medicine, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT02286986 - Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy | Biotech Hunter | Biotech Hunter